Cited by

• Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.

  Lasnon C, Desmonts C, Quak E, Gervais R, Do P, Dubos-Arvis C, Aide N. Lasnon C, et al. Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):985-96. doi: 10.1007/s00259-013-2391-1. Epub 2013 Apr 6. Eur J Nucl Med Mol Imaging. 2013. PMID: 23564036 Free PMC article. Clinical Trial.
• Patient-Specific Method of Generating Parametric Maps of Patlak K(i) without Blood Sampling or Metabolite Correction: A Feasibility Study.

  Sayre GA, Franc BL, Seo Y. Sayre GA, et al. Int J Mol Imaging. 2011;2011:185083. doi: 10.1155/2011/185083. Epub 2011 Sep 7. Int J Mol Imaging. 2011. PMID: 21912742 Free PMC article.
• Incidence and Significance of Incidental Focal Thyroid Uptake on (18)F-FDG PET Study in a Large Patient Cohort: Retrospective Single-Centre Experience in the United Kingdom.

  Agrawal K, Weaver J, Ul-Hassan F, Jeannon JP, Simo R, Carroll P, Hubbard JG, Chandra A, Mohan HK. Agrawal K, et al. Eur Thyroid J. 2015 Jun;4(2):115-22. doi: 10.1159/000431319. Epub 2015 Jun 11. Eur Thyroid J. 2015. PMID: 26279997 Free PMC article.
• Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.

  Kuhnert G, Boellaard R, Sterzer S, Kahraman D, Scheffler M, Wolf J, Dietlein M, Drzezga A, Kobe C. Kuhnert G, et al. Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):249-258. doi: 10.1007/s00259-015-3165-8. Epub 2015 Aug 18. Eur J Nucl Med Mol Imaging. 2016. PMID: 26280981
• Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients.

  Muzahir S, Jeraj R, Liu G, Hall LT, Rio AM, Perk T, Jaskowiak C, Perlman SB. Muzahir S, et al. Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):162-8. eCollection 2015. Am J Nucl Med Mol Imaging. 2015. PMID: 25973337 Free PMC article.